Proactive investorsLogo Proactive Investors UK Website

Search field
Additional information
Additional Information
Market: TSX, NYSE
Sector: Gold Mining
Epic: ABX
News: Latest news
Web Site: Barrick Gold
Other Articles: 14-01-201007-12-200901-12-2009

RSS - Subscribe to the News Today on Proactive UK ▼

Wednesday March 17, 09:01SmartFocus, Amphion Innovations and National Milk Records confirmed for March 18 Forum

The presentations will start at 6:00pm and finish at approx 7:30pm. After the presentations are complete the directors will also be available to take questions during a free canapé and wine reception.

FULL ARTICLE ►

RSS - Subscribe to the News Today on Proactive AU ▼

Thursday March 18, 12:26Healthcare & Biotech companies to present at "Ultimate Healthcare & Biotechnology Event 2010”

We have a cracking line-up for March 24, as we return to Healthcare & Biotech sector at our One2One Investor Forum. Seats are limited, to avoid disappointment, register now.

FULL ARTICLE ►

RSS - Subscribe to the News Today on Proactive CN ▼

Monday March 15, 09:01China's growth boosting commodity prices

The latest economic figures from China have put pressure on the dollar and boosted a number of high-yielding currencies, including the Australian dollar and the South African rand.

FULL ARTICLE ►
Barrick Gold

Barrick Gold

Barrick is the world’s pre-eminent gold producer, with a portfolio of 27 operating mines, many advanced exploration and development projects located across five continents, and large land positions on the most prolific and prospective mineral trends. The Company also has the largest reserves in the industry, with 124.6 million ounces of proven and probable gold reserves, 6.2 billion pounds of copper reserves and 1.03 billion ounces of contained silver within gold reserves as at December 31, 2007.

In 2007, Barrick produced 8.06 million ounces of gold at a cash cost of $350 per ounce. In addition, the Company produced 402 million pounds of copper at a total cash cost of $0.83 per pound. For 2008, Barrick is targeting gold production of 7.6-8.1 million ounces and copper production of approximately 380-400 million pounds. Total cash costs are expected to be $390-$415 per ounce of gold and $1.15-$1.25 per pound of copper.

Thursday, January 14, 2010

Barrick files motion to block Goldcorp's attempt to buy 70% in El Morro Project from New Gold

company news image

 

By Dorothy Kosich, Mineweb.com

Former Barrick CEO Randall Oliphant's triumph over his former company in sale of the El Morro project ownership may prove short-lived as an angry Barrick filed a motion with the Ontario Superior Court of Justice to block the US$465 million deal between New Gold and Goldcorp.

Oliphant is now the chairman of New Gold, while Goldcorp is Barrick's joint venture partner on the US$2.7 billion Pueblo Viejo project in the Dominican Republic. Pueblo Viejo has proven and probable reserves of 20.4Moz gold, 117Moz silver and 424Mlb copper.

On October 11, 2009, Xstrata Copper, which owns 70% of the El Morro Mining Project, and Barrick entered into a US$465 million sale agreement for the world's top gold company to purchase the Xstrata interest in the El Morro copper-gold project in Chile.

In documents filed with the Ontario Superior Court in Toronto, Barrick said El Morro is located near the company's massive Pascua-Lama gold and silver project that spans two nations. Barrick said El Morro "offers the potential to Barrick of unique cost-sharing and future operating synergies."

Xstrata's joint venture partner in El Morro, New Gold, had the right of first refusal to purchase the majority interest in the project. Meanwhile, Barrick presented a $300 million all-cash offer to New Gold for its 30% interest in El Morro.

However New Gold decided to make a deal with Goldcorp. Under the arrangement, Goldcorp agreed to lend $463 million in New Gold to allow the junior company to buy Xstrata's 70% stake. New Gold planned to then transfer that stake to Goldcorp in exchange for an additional $50 million payment to New Gold, which wanted to retain its 30% interest in El Morro.

The project's most recent feasibility study estimated it will cost at least $2.5 billion to build El Morro. Goldcorp had also agreed to finance New Gold's share of the project costs, which could rise to as much as $3 billion.

However, Barrick insists that New Gold failed to properly and legally exercise the right of first refusal on El Morrow by January 11, 2010, "As a result, New Gold's Right of First Refusal has now expired," the company asserted in its Statement of Claim filed with the court.

Barrick claims New Gold "improperly provided Goldcorp with extensive confidential documentation and information concerning the El Morro Mining Project. Neither Goldcorp nor New Gold has a right to use such information either directly or indirectly for the purpose of the acquisition of the Xstrata Interest by Goldcorp. Nor does Goldcorp have the right to retain the confidential documentation and information in has received from New Gold."

Meanwhile, Barrick contends Xstrata Copper has breached its obligations to Barrick when Xstrata said it doesn't intend to close the sale agreement with Barrick. Instead, Xstrata intends to transfer its interest to New Gold pursuant to New Gold's exercise of the Right of First Refusal.

In its claim before the court, Barrick asked the court to declare that New Gold's Right of First Refusal has expired, and can no longer be exercised. Barrick also asked the court to find the New Gold/Goldcorp Agreement is unlawful and ineffective.

Barrick also asks that restitution be made.

Goldcorp responded late Wednesday that it is reviewing Barrick's claim with its legal counsel.

In a statement, the company said, "Goldcorp has acted in good faith and is confident that it has acted lawfully and appropriately in all aspects of this transaction and intends to vigorously defend itself against the claim.

AddThis Feed Button
Register here to be notified of future Barrick Gold articles.

Investors interested in Barrick Gold recently viewed


No investment advice

The Company is a publisher and is not registered with or authorised by the Financial Services Authority (FSA). You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.